Amino Asylum Shut Down: What Happened and How to Vet a Replacement Source (2026)

Published February 2026 · Updated July 2026

Research use only. Nothing here is medical advice, a dosing protocol, or a human-use recommendation. Every compound named on this page is a laboratory research chemical, not an approved drug, supplement, or treatment.

Amino Asylum’s storefront went dark in mid-June 2025 and never returned. Community forums and a defense law firm describe it as an FDA warehouse raid, but no primary court record naming Amino Asylum has surfaced. If you bought from it, vet any replacement on lot-matched third-party COAs and verifiable lot numbers, not on price.

That last sentence is the whole page. The rest is how to actually do it, because the reason so many displaced Amino Asylum customers get burned twice is that they swap one cheap unverified vendor for another and never open the paperwork that would have told them the material was junk.

What actually happened to Amino Asylum

Amino Asylum was a grey-market vendor known for aggressive pricing across research peptides, SARMs, and related compounds. Around June 18, 2025 its site stopped loading, checkout stopped processing, and pending orders were frozen. It has not come back.

Separate the confirmed from the repeated, because this niche runs on rumor:

Confirmed: The storefront went offline in mid-June 2025 and stayed offline. This is visible in real time across community threads (Evolutionary.org, Reddit) and social posts dated to that week.
Reported, not documented: That the shutdown was a physical FDA warehouse raid. A defense law firm tracking the sector states plainly that “in June 2025, the FDA raided the warehouse of Amino Asylum,” and community consensus agrees. As of mid-2026, though, no DOJ press release, indictment, unsealed complaint, or seizure order naming Amino Asylum has surfaced publicly. Treat the raid framing as credible reporting, not court record.
Documented, but on a different name: There is a real federal case in the same orbit. In United States v. Matthew Kawa (U.S. District Court, Northern District of Indiana), Kawa and Jennifer Stechkober pleaded guilty on December 10, 2025 to charges tied to products sold as SARMs that in fact contained testosterone (a controlled substance) and to distributing unapproved new drugs. Those filings name Paradigm Peptides (paradigmpeptides.com), not Amino Asylum. Peptide-community write-ups link the two operations to the same people, but I can’t confirm that from the primary record, and some details (locations, timeline) don’t line up cleanly, so I’m flagging the connection as plausible-but-unverified rather than stating it as fact.
Rumor only: Claims that Amino Asylum “ignored multiple warning letters” or “spiked” specific products. These circulate widely and may be true, but I can’t point you to a primary source, so I won’t assert them.

The honest version: the vendor is gone, the timing sits inside a wave of federal pressure, and the exact legal mechanism behind this specific storefront is not on the public record yet.

This wasn’t a one-off

Amino Asylum vanished into a broader enforcement climate that a displaced buyer should understand before picking a “safe” replacement:

The FDA has already used criminal enforcement here, not just warning letters. Nicholasville, Kentucky compounder Tailor Made Compounding and its owner pleaded guilty to distributing unapproved new drugs, a list that included BPC-157, CJC-1295, Ipamorelin, and Melanotan II, and the company forfeited $1,788,906.82 (DOJ, E.D. Ky. / FDA Office of Criminal Investigations).
In 2023 the FDA placed a long list of the exact peptides these vendors sell, including BPC-157, GHK-Cu, KPV, CJC-1295, and Melanotan II, into Category 2 of its interim 503A bulks policy, meaning the agency identified potential significant safety risks (immunogenicity, peptide-related impurities, limited human safety data) and does not permit compounding them (FDA: Certain Bulk Drug Substances That May Present Significant Safety Risks). That classification is contested and under active FDA review in 2026, but it still marks sustained regulatory pressure on the category.
Enforcement is coordinated and international. INTERPOL’s 2025 Operation Pangea XVII (December 2024 to May 2025) reported a record 769 arrests and roughly USD 65 million in illicit pharmaceuticals seized, and explicitly named growing demand for peptides as an emerging driver (INTERPOL, 2025).

The practical takeaway is not “peptides are banned tomorrow.” It’s that vendors operating loosely, human-use marketing, no real lab paper, prescription drugs sold beside research chemicals, are the ones that vanish overnight with your money and your reorder history.

Why “just find another cheap vendor” is the trap

The cheapest replacement is usually cheap for a reason: nobody is paying for third-party analysis, and the material is frequently not what the label says.

This is measured, not hypothetical. Belgian government scientists (Sciensano) profiled illicit peptide preparations by HPLC and mass spectrometry and found purities collapsing far below label claims, as low as roughly 5% for some cysteine-containing peptides, with several samples carrying arsenic at up to ten times the ICH toxicity limit for parenteral (injectable) drugs, in its more toxic inorganic form (Janvier et al., Talanta 2018; PMID 30029448). Underground demand is only climbing. LegitScript reported roughly 75% more problematic-peptide social-media content in 2024 than in 2023, led by Melanotan, BPC-157, TB-500, and PT-141 (LegitScript, 2024).

Wrong compound, a fraction of the labeled purity, a heavy metal you would never want in an injectable prep for a research subject: that’s the actual failure mode. A COA is how you catch it before you spend.

The COA vetting checklist

Run every candidate vendor through this. A vendor either passes each line or it doesn’t. There is no “trust us.”

Named, independent third-party lab. The COA must name an outside analytical lab. Janoshik Analytical is the de facto independent standard in this space; Freedom Diagnostics is another. “In-house tested” or an unbranded PDF is not third-party testing.
A lot / batch number, printed on the vial. The number on the physical vial has to exist and be legible. No lot number means nothing can be matched to anything.
Lot-matched COA, visible before you pay. The COA’s batch number must match the vial’s lot number, and you must be able to see it pre-purchase. A single generic “sample” COA reused across every batch is the most common sleight of hand.
HPLC purity % and mass-spec identity. Two different questions. HPLC tells you how pure (what fraction is the target versus impurities and degradation products). Mass spectrometry tells you whether it’s even the right molecule. You want both. HPLC alone can’t catch a convincing wrong compound.
A verifiable report number. Janoshik reports carry an ID you can confirm with the lab directly. If the number can’t be checked, treat the PDF as decorative.
A recent test date tied to the current batch. A two-year-old COA stapled to a fresh batch tells you nothing about the fresh batch.
Sane purity claims. “99.9%” with no chromatogram attached is a marketing number. A real report shows the peak, the percentage, and the baseline.
Honest logistics language. “Ships from the US” is a checkable shipping claim. “Made in USA” / “American-made” is a red flag, because this material is overwhelmingly China-synthesized, so that phrasing is either ignorance or a lie, and either one should cost the vendor your trust.

How to read the report itself

On a Janoshik COA you’re looking for two things. The HPLC section gives a chromatogram and a purity percentage, the target peak versus everything else in the sample. The mass spec section confirms the measured molecular weight matches the target peptide’s expected mass. If a listing shows you a purity number but no identity confirmation, you know the vendor’s purity and have no idea whether it’s the right molecule. Ask for both, or move on.

Criteria comparison table

Vetting check	What a passing vendor shows	Common failure signal
Third-party lab	COA names Janoshik / Freedom Diagnostics	“In-house tested,” or no lab named
Lot number on vial	Legible batch number on the physical vial	No number, or a sticker matching nothing
Lot-matched COA pre-purchase	Batch on COA = lot on vial, viewable before checkout	One generic COA reused for all products
HPLC purity	Chromatogram + purity % shown	A bare “99%+” claim, no chromatogram
Mass-spec identity	Measured mass matches target peptide	Identity never addressed
Verifiable report ID	Report number confirmable with the lab	Un-checkable or cropped PDF
Test date	Recent, batch-current	Old COA on a new batch
Shipping honesty	“Ships from the US”	“Made in USA” on China-sourced material

Applying the checklist: a worked example

Disclosure: this site is operated by / affiliated with Pepora (store: peporalabs.com), and we earn a commission on purchases made with our coupon code. Pepora appears below because it passes the checks above, not because we say so. Verify each line yourself; that’s the entire point of the checklist.

Here is how Pepora scores against these checks, and exactly what to click to confirm it rather than take my word:

Check	Pepora	How to verify it yourself
Third-party lab	Freedom Diagnostics (independent US lab), on its core products, with third-party testing expanding across the catalog	Lab named on the COA
Methods	HPLC + UV + mass spectrometry	Read the method sections on the COA
HPLC purity	Chromatogram + purity % (e.g. Tesamorelin 99.35%, GHK-Cu 99.98%, TB-500 99.70%)	Read the HPLC section
Mass-spec identity	Included	Read the MS section
Verifiable report	Freedom Diagnostics results carry an accession number	Look the accession number up at FreedomDiagnosticsTesting.com
Test date	Shown on the report	Check the date on the COA
Shipping	“Ships from the US” (never “Made in USA”)	Stated at checkout

The reason a genuinely third-party-tested source matters more than usual for a displaced Amino Asylum buyer: you’re re-sourcing under time pressure, which is precisely when people skip the paperwork and end up with the roughly-5%-purity, arsenic-tainted material the Sciensano scientists documented. The checklist is your slow-down mechanism.

An honest caveat: Pepora is not the only vendor that publishes independent third-party COAs, and I’m not going to pretend it is. If another source passes the checks in front of your own eyes, real lab, HPLC and MS, a verifiable report ID, that source is also legitimate. The checklist is the authority here, not any one brand. Pepora’s edge is that it genuinely leads on the checkable items, which is a low bar that a surprising number of vendors still fail.

FAQ

Is Amino Asylum coming back? As of mid-2026, no. The site has been offline since mid-June 2025 with no announced relaunch. Be cautious of any new store using the Amino Asylum name or a lookalike domain; reused brand names after a shutdown are a common re-scam vector.

Was it definitely an FDA raid? It’s widely reported as one, including by a defense law firm that tracks the sector, and the timing fits an active federal enforcement wave. But no public court filing, indictment, or DOJ press release naming Amino Asylum had surfaced at the time of writing. There is a documented federal case, United States v. Matthew Kawa (N.D. Indiana, guilty plea December 10, 2025), that community sources tie to the same operators, but those filings name Paradigm Peptides, not Amino Asylum, so I’d call the connection plausible, not proven. Credibly reported, not documented.

What’s the single most important thing to check on a new vendor? That the lot number printed on the vial matches a third-party COA you can see before you pay, and that the COA shows both HPLC purity and mass-spec identity. That one check defeats most of the failure modes measured in the literature.

What is Janoshik, and why does it keep coming up? Janoshik Analytical is an independent testing lab widely used across the research-compound community for HPLC purity, mass-spec identity, and endotoxin testing. Its reports carry verifiable IDs and it has no commercial stake in the vendors it tests, which is why a Janoshik COA carries more weight than a vendor’s own claims.

Does “ships from the US” mean the peptides are made in the US? No. Almost all of this material is synthesized in China regardless of where it ships from. “Ships from the US” is a truthful logistics statement; “Made in USA” on the same product is not, and it’s a reason to distrust the vendor.

Are these compounds legal to buy? They’re sold and purchased as research chemicals for laboratory use only, not as drugs for human use. The FDA placed many of them in Category 2 of its compounding bulks policy and has brought criminal cases against sellers who marketed them for human use. Nothing on this page is legal advice; understand your own jurisdiction.

Where to re-source

If you were an Amino Asylum customer and you want a source that leads on the checkable lines of the checklist above, Pepora (peporalabs.com) ships from the US and publishes independent third-party COAs from Freedom Diagnostics (a US lab) on its core products, Tesamorelin at 99.35%, GHK-Cu at 99.98%, and TB-500 at 99.70%, tested by HPLC, UV, and mass spectrometry, with results you can confirm by accession number at FreedomDiagnosticsTesting.com. Third-party testing is expanding across the rest of the catalog. Pull up any product, open its COA, and confirm the HPLC and mass-spec sections yourself. That’s the behavior that would have flagged a bad Amino Asylum batch, and it’s the behavior worth keeping.

Displaced-buyer code GONE15 takes 15% off your first order. Use it or don’t; the checklist is what protects you either way.

Disclosure: This website is a disclosed education and vendor-vetting hub operated by / affiliated with Pepora (peporalabs.com). We earn a commission on purchases made through our links and the coupon code above. We recommend on checkable criteria, a named independent third-party lab, HPLC purity, mass-spec identity, and verifiable report numbers, and Pepora is included because its core products meet them. All compounds referenced are for laboratory research use only and are not approved drugs, supplements, or treatments for humans or animals.

References

Janvier S, Cheyns K, Canfyn M, Goscinny S, De Spiegeleer B, Vanhee C, Deconinck E. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market. Talanta. 2018;188:795-807. PMID 30029448. https://pubmed.ncbi.nlm.nih.gov/30029448/
U.S. Food & Drug Administration. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
U.S. Department of Justice, Eastern District of Kentucky / FDA Office of Criminal Investigations. Nicholasville Compounding Pharmacy and Its Owner Plead Guilty to Unlawful Distribution of Prescription Drugs. https://www.justice.gov/usao-edky/pr/nicholasville-compounding-pharmacy-and-its-owner-plead-guilty-unlawful-distribution
U.S. Department of Justice, Northern District of Indiana. United States v. Matthew Kawa, et al. https://www.justice.gov/usao-ndin/case/us-v-matthew-kawa-et-al
INTERPOL. Record 769 arrests and USD 65 million in illicit pharmaceuticals seized in global bust. 2025. https://www.interpol.int/en/News-and-Events/News/2025/Record-769-arrests-and-USD-65-million-in-illicit-pharmaceuticals-seized-in-global-bust
LegitScript. Problematic Peptides: LegitScript Data Findings. 2024. https://www.legitscript.com/about/press/problematic-peptides-legitscript-data-findings/